Alle verbonden artikelen

Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.

Auteurs : Dubruille S, Libert Y, Roos M, Vandenbossche S, Collard A, Meuleman N, Maerevoet M, Etienne AM, Reynaert C, Razavi D, Bron D
Jaar : 2015
Journal : J Geriatr Oncol
Volume : 24(3)
Pagina's : 294-301

Does Multimedia Education with 3D Animation Impact Quality and Duration of Urologists' Interactions with their Prostate Cancer Patients?

Auteurs : Peltier A, Aoun F, Ameye F, Andrianne R, De Meerleer G, Denis L, Joniau S, Lambrecht A, Billiet I, Vanderdonck F, Roumeguère T, Van Velthoven R
Jaar : 2015
Journal : Adv Ther
Volume : 32
Pagina's : 863-73

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

Auteurs : Pagani O, Ruggeri M, Manunta S, Saunders C, Peccatori F, Cardoso F, Kaufman B, Paluch-Shimon S, Gewefel H, Gallerani E, Abulkhair O, Pistilli B, Warner E, Saloustros E, Perey L, Zaman K, Rabaglio M, Gelber S, Gelber Rd, Godhirsch A, Korde L, Azim HA, Partridge AH
Jaar : 2015
Journal : Breast
Volume : 24(3)
Pagina's : 201-7

Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.

Auteurs : Zardavas D, Piccart-Gebhart M
Jaar : 2015
Journal : Am Soc Clin Oncol Educ Book
Volume : 35
Pagina's : e183-90

Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development.

Auteurs : Stahel R, Bogaerts J, Ciardiello F, De Ruysscher D, Dubsky P, Ducreux M, Finn S, Laurent-Puig P, Peters S, Piccart-Gebhart M, Smit E, Sotiriou C, Tejpar S, van Cutsem E, Tabernero J
Jaar : 2015
Journal : Cancer Treat Rev
Volume : 41(2)
Pagina's : 129-135

Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study.

Auteurs : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2015
Journal : J Geriatr Oncol
Volume : 6(5)
Pagina's : 401-10

New approaches for improving outcomes in breast cancer in Europe.

Auteurs : Di Leo A, Curigliano G, Diéras V, Malorni L, Sotiriou C, Swanton C, Thompson A, Tutt A, Piccart-Gebhart M
Jaar : 2015
Journal : Breast
Volume : 24(4)
Pagina's : 321-330

Checkpoint inhibitors in bladder and renal cancers: results and perspectives.

Auteurs : Aoun F, Kourie HR, Sideris S, Roumeguère T, Van Velthoven R, Gil T
Jaar : 2015
Journal : Immunotherapy
Volume : 7
Pagina's : 1259-71

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.

Auteurs : Azim HA, Vingiani A, Peccatori F, Viale G, Loi S, Pruneri G
Jaar : 2015
Journal : Breast
Volume : 24(3)
Pagina's : 290-3

Tailoring therapies - improving the management of early breast cancer: St GallenInternational Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Auteurs : Coates AS, Winer EP, Goldhirsch A, Gelber Rd, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ
Jaar : 2015
Journal : Ann Oncol
Volume : 26(8)
Pagina's : 1533-46

BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.

Auteurs : Willaert W, Van Der Speeten K, Liberale G, Ceelen W
Jaar : 2015
Journal : BMC Cancer
Volume : 15
Pagina's : 980

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers.

Auteurs : Denkert C, Von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, Pfitzner BM, Salat C, Loi S, Schmitt WD, Schem C, Fisch K, Darb-Esfahani S, Mehta K, Sotiriou C, Wienert S, Klare P, André F, Klauschen F, Blohmer J, Krappmann K, Schmidt M, Tesch H, Kümmel S, Sinn P, Jackisch C, Dietel M, Reimer T, Untch M, Loibl S
Jaar : 2015
Journal : J. Clin. Oncol.
Volume : 33(9)
Pagina's : 983-91

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.

Auteurs : El Hajj P, Gilot D, Migault M, Theunis A, Van Kempen LC, Sales F, Fayyad-Kazan H, Badran B, Larsimont D, Awada A, Bachelot L, Galibert MD, Ghanem G, Journe F
Jaar : 2015
Journal : Br J Cancer
Volume : 113(1)
Pagina's : 91-8

Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.

Auteurs : Boyle FM, Smith IE, + collaborators (among others :, Piccart-Gebhart M, Finkelstein D
Jaar : 2015
Journal : Eur. J. Cancer
Volume : 51(6)
Pagina's : 685-96

New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.

Auteurs : Saiselet M, Gacquer D, Spinette A, Craciun L, Decaussin-Petrucci M, Andry G, Detours V, Maenhaut C
Jaar : 2015
Journal : BMC Genomics
Volume : 16
Pagina's : 828

Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination.

Auteurs : Cnops L, Gerard M, Vandenberg O, Van den Wijngaert S, Heyndrickx L, Willems E, Demeulemeester K, De Clerck H, Dediste A, Callens S, De Munter P, Vlieghe E, Bottieau E, Wuillaume F, Van Esbroeck M, Ariën KK
Jaar : 2015
Journal : Clin Infect Dis
Volume : 60(11)
Pagina's : 1725-26

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Auteurs : Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L
Jaar : 2015
Journal : Ann Oncol
Volume : 26
Pagina's : 2408-19

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.

Auteurs : Machiels JP, Specenier P, Krauß J, Dietz A, Kaminsky MC, Lalami Y, Henke M, Keilholz U, Knecht R, Skartved NJ, Horak ID, Pamperin P, Braun S, Gauler TC
Jaar : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(1)
Pagina's : 13-20

A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours.

Auteurs : Venugopal B, Awada A, Evans TR, Dueland S, Hendlisz A, Rasch W, Hernes K, Hagen S, Aamdal S
Jaar : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(4)
Pagina's : 785-92

No significant viral transcription detected in whole breast cancer transcriptomes.

Auteurs : Fimereli D, Gacquer D, Fumagalli D, Salgado R, Rothé F, Larsimont D, Sotiriou C, Detours V
Jaar : 2015
Journal : BMC Cancer
Volume : 15(null)
Pagina's : 147